Page last updated: 2024-10-29

amrinone and Sepsis

amrinone has been researched along with Sepsis in 2 studies

Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.

Sepsis: Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jurasinski, CV1
Kilpatrick, L1
Vary, TC2

Other Studies

2 other studies available for amrinone and Sepsis

ArticleYear
Amrinone prevents muscle protein wasting during chronic sepsis.
    The American journal of physiology, 1995, Volume: 268, Issue:3 Pt 1

    Topics: Abscess; Adenosine Triphosphate; Amrinone; Animals; Cyclic AMP; Eating; Insulin; Kinetics; Male; Mus

1995
Amrinone prevents the inhibition of muscle pyruvate dehydrogenase complex activity during sepsis.
    Shock (Augusta, Ga.), 1996, Volume: 5, Issue:3

    Topics: Amrinone; Animals; Enzyme Inhibitors; Lactates; Lactic Acid; Least-Squares Analysis; Linear Models;

1996